Table 1 Patients’ and tumors’ characteristics.
IBC-NST | IMPC | Mixed IMPC/IBC-NST | p-value | |
|---|---|---|---|---|
Total patient number | 36 | 36 | 8 | |
Median years of age (range) | 62 (37–83) | 63 (33–85) | 65.5 (34–69) | 0.9921 |
Median of Ki67 LI (range) | 15 (1–100) | 15 (1–90) | 23 (5–90) | 0.5791 |
Grade | 0.7282 | |||
I | 3 (8.3%) | 3 (8.3%) | 1 (12.5%) | |
II | 20 (55.6%) | 23 (63.9%) | 3 (37.5%) | |
III | 13 (36.1%) | 10 (27.8%) | 4 (50%) | |
T | 0.7022 | |||
1 | 14 (38.9%) | 14 (38.9%) | 3 (37.5%) | |
2 | 11 (30.6%) | 8 (22.2%) | 4 (50%) | |
3 | 8 (22.2%) | 9 (25%) | 0 (0%) | |
4 | 3 (8.3%) | 3 (8.3%) | 1 (12.5%) | |
NA | 2 (5.6%) | |||
N | 0.942 | |||
0 | 13 (36.1%) | 11 (30.6%) | 3 (37.5%) | |
1 | 9 (25%) | 9 (25%) | 3 (37.5%) | |
2 | 6 (16.7%) | 3 (8.3%) | 1 (12.5%) | |
3 | 5 (13.9%) | 7 (19.4%) | 1 (12.5%) | |
NA | 3 (8.3%) | 6 (16.7%) | ||
ER | 0.1212 | |||
+ | 28 (77.8%) | 34 (94.4%) | 7 (87.5%) | |
− | 8 (22.2%) | 2 (5.6%) | 1 (12.5%) | |
PR | 0.0182 | |||
+ | 18 (50%) | 28 (77.8%) | 7 (87.5%) | |
− | 18 (50%) | 8 (22.2%) | 1 (12.5%) | |
HER2 | 0.6012 | |||
+ | 5 (13.9%) | 9 (20.4%) | 1 (12.5%) | |
− | 31 (86.1%) | 35 (79.6%) | 7 (87.5%) |
